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Isolated Hemihyperplasia (IHH) is a rare disorder that results in the enlargement of a portion of a limb, a
complete limb or an entire half of an individual’s body. We describe an 11 year-old girl with isolated
hemihyperplasia of her right upper and lower extremities, breast, and vulvar region. A mass consisting of
asymmetric enlargement and fatty inﬁltration of the right adductor compartment was ﬁrst noticed at
approximately 4 years of life and progressed dramatically to severely affect her gait. We surgically
debulked the thigh and resected the excess skin to restore symmetry. The patient did well post-
operatively, achieved excellent cosmesis, and restoration of gait.
 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Isolated Hemihyperplasia (IHH) is a rare disorder that results in
the enlargement of a portion of a limb, a complete limb, or an entire
half of an individual’s body [1e4]. The term hemihyperplasia is
preferred to prior usage of hemihypertrophy since the former better
represents the increased cellularity of the overgrown tissue. Hem-
ihyperplasia can occur in isolation or as part of a pleotropic genetic
syndrome such as Beckwith-Wiedmann Syndrome (BWS), Proteus
Syndrome (PS) or Russell-Silver Syndrome (RSS) [5,6]. Whether
isolated or syndromic, there is an increased risk of embryonal
malignancy associated with hemihyperplasia likely attributable to
the genetic cause of the overgrowth [7e11]. Though tremendous
progress has been made to identify the speciﬁc genetic etiology for
some hemihyperplasia syndromes, isolated hemihyperplasia has
been more difﬁcult to deﬁne at this level because of probable so-
matic mosaicism in the affected tissue. This also complicates sur-
veillance for these patients since recommendations have evolved
over time as new malignancies have occurred at younger ages [12].
The deformity and severely compromised function caused by: þ1 410 502 3092.
r).
c. This is an open access article undeextreme hemihyperplasia can cause tremendous morbidity for
patients, particularly the young patient presented here. We present
a case report of successful surgical management of extreme uni-
lateral hemihyperplasia with severe lower extremity manifesta-
tions. To the best of our knowledge, this is the ﬁrst case report in the
medical literature of such a unique case.1. Case report
An 11 year-old girl was referred for marked right-side hemi-
hyperplasia. By her ﬁfth year of life, the patient’s parents had ﬁrst
noted the right lower extremity to be larger than the left. Pituitary
imaging in 2007 was noted to be normal, as were bone age and
renal ultrasound studies. In 2008, initial imaging of the right lower
extremity (LE) showed fatty inﬁltration of the muscles. Malignancy
screening including abdominal ultrasounds and alpha fetoprotein
(AFP) were negative. She had no syndromic manifestations of a
recognized hemihyperplasia syndrome. At presentation, the pa-
tient weighed 57.6 kg and her right LE was markedly enlarged
compared to the contralateral LE (Fig. 1) such that when lying on
her back she was externally rotated 40. Additionally, her right
vulvar region, breast and upper extremity were larger than ther the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. The patient demonstrated marked hyperplasia of the right lower extremity
posteriorly pre-operatively.
Fig. 2. Axial (top) and coronal (bottom) magnetic resonance imagining demonstrating
lipomatous inﬁltration of the right adductor musculature.
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girl with normal development and cognition. There was no family
history of hemihyperplasia or other inherited conditions, however
her mother is currently in remission from an aggressive form of
breast cancer.
In 2013 magnetic resonance imagining at our institution
revealed lipomatous inﬁltration of the right adductor musculature
without bony or neurovascular involvement (Fig. 2). The hyper-
trophic LE had begun to cause signiﬁcant form and functional
problems, affecting her gait and quality of life. She had been seen atseveral outside institutions and told that her IHHwas not amenable
to surgical management.
After thorough review of the imaging, we felt that a surgical
approach to restore the patient’s gait and reduce the size of the LE
was possible. We beganwith a medial thigh incision extending into
the gluteal crease. The surrounding musculature demonstrated
signs of a mass effect with marked ﬂattening and stretching of the
adjacent muscles. Careful dissection continued until the gracilis
musculature and its neurovascular pedicle were identiﬁed and
preserved. The biceps femoris, the semimembranosus, as well as the
adductormuscles including the pectineus and adductor brevis were
identiﬁed with careful dissection to preserve their innervation and
vascular pedicles. We were able to safely identify and dissect the
sciatic nerve along its proximal course with identiﬁcation and
preservation of the distal tibial and peroneal branches. This allowed
mobilization of the sciatic nerve to protect it during our dissection of
the mass. We identiﬁed the profundus vessels and these were also
preserved (Fig. 3). The large mass of the adductor muscles, which
was inﬁltrated with fat, could then be safely excised. The resected
specimen measured 46 cm  32 cm and weighed approximately
8 kg (Fig. 4).We proceeded to excisemuch of the redundant skin and
fat of the thigh to provide an aesthetic tissue contour.
The patient underwent uneventful observation overnight in
the ICU before transfer to a ﬂoor bed and uneventful discharge.
Surgical pathology demonstrated a mass consisting of ﬁbromus-
cular tissue with massive lipomatous inﬁltration. Within a week
of surgery, the patient was able to walk without gait abnormal-
ities and minimal use of an assistive device. On her ﬁrst visit to
the clinic, the incisions were healing well and she demonstrated
normal gait, a signiﬁcant reduction in the mass of her right thigh,
and no post-operative complications. At her 8-month follow-up
visit, her gait had improved greatly, the incisions were well-
healed with minimal scarring, and no complications were present
(Fig. 5).
Fig. 3. Preserved anatomy of the thigh following excision with the preserved sciatic
nerve (black arrow), biceps femoris, and semitendinosis.
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Hemihyperplasia (HH) is a rare overgrowth disorder that can
manifest in isolation, isolated hemihyperplasia (IHH), or as a feature
of genetic syndromes and consists of both a length and circumfer-
ential discrepancy compared to the contralateral side [1e3]. IHH
demonstrates a right-sided and female predominance, the exact
reason for which remains unknown [10,13]. The overgrowth can
appear early in childhood and can becomemore or less pronounced
with age. The speed of growth is variable but often begins to
accelerate after early childhood. The prevalence of isolated hemi-
hyperplasia is difﬁcult to estimate because there are few large-scale
epidemiologic studies, some syndromic patients may be mis-
classiﬁed as isolated, and the overgrowth diagnosis is often made
on a clinical basis since the genetic etiology may not be known.
Despite these issues, three published studies suggest an incidence
of isolated hemihyperplasia of 1:13,200 to 1:86,000 [14e16].
A key feature of hemihyperplasiadwhether isolated or part of a
syndromedis the increased risk of intra-abdominal tumors of
embryonal origin. Hoyme et al. was the ﬁrst to report a 5.9%Fig. 4. The hypertrophied mass after surgical excision measured 12  18 cm and
weighing 8 kg.incidence of tumors in 168 IHH patients including Wilms tumor,
hepatoblastoma, adrenal cell carcinoma, and small bower leiomyo-
sarcoma [10]. Tumor surveillance was already recommended for
individualswith a variety of syndromes includingHHand Beckwith-
Wiedemann syndrome, but Hoyme’s study gave strong support to
regular monitoring of patients with IHH. Today, the recommended
surveillanceprotocol for all patientswith IHH includes anabdominal
ultrasound every 3 months to 8 years of age and serum AFP quan-
tiﬁcation every 3 months to 4 years of age. This surveillance should
commence after a comprehensive evaluation for accompanying
syndromic features and family history of HH which may help direct
molecular testing to conﬁrm a genetic diagnosis.
Martin [7] described an abnormal methylation proﬁle on two
genes on chromosome 11p15 (KCNQ1OT1 and H19) in two distinct
imprinted regions in 8/27 patients with IHH. This abnormal
methylationwas postulated to disrupt the normal balance between
the maternal and paternal expression of the genes in these regions,
thereby allowing overexpression of IGF-2 (growth promoter insu-
lin-like growth factor 2) and repression of CDKN1C (a tumor sup-
pressor). Subsequent research has shown that abnormal
methylation of the 11p15 region is not as common in IHH patients
as is the presence of paternal uniparental disomy (pUPD). In a study
of 47 patients with IHH, it was found that 61% had pUPD at chro-
mosome 11p15 [8,9]. Though this is in contrast to BWS patients in
whom an imprinting center defect is more common than paternal
UPD, the common genetic defects suggest that IHH may be on one
end of the BWS spectrum. Further study is needed to clarify this
relationship as there aremany patients still with a clinical diagnosis
of BWS and IHH without a deﬁned genetic or epigenetic etiology.
Perhaps some of these patients harbor their genetic or epigenetic
abnormality only in the affected, overgrown tissue due somatic
mosaicism. A recent article by Lindhurst et al. recently demon-
strated this in a cohort of patients with congenital, progressive
segmental ﬁbroadipose overgrowth in which somatic mutations in
PIK3CA were detected in the abnormal, hyperplastic tissue but not
the peripheral blood white blood cell DNA [17]. Research is ongoing
at our institution to compare our patient’s peripheral blood whole
exome sequencing with that from affected tissue in an effort to
identify the genetic etiology of her hemihyperplasia.
At least twelve different syndromes include HH [1]. HH is most
oftenassociatedwithBeckwith-Wiedemannsyndrome(BWS),CLOVE
syndrome (congenital lipomatous overgrowth, vascular malforma-
tions, and epidermal nevi), and Proteus syndrome [5,6,18]. Studies
have shown that HH is present in 12.5e15.9% of patients with BWS
along with other classic ﬁndings such as macroglossia, macrosomia,
and abdominal wall defects including omphalocele or diastasis recti
[19,20]. Patients with the even more uncommon Proteus syndrome
have variable presentations as the disease is affects multiple organ
systems. Its diagnosis can be confused with hemihyperplasia, but
their rate of overgrowth tends to be asymmetric in nature as opposed
to the uniform rate of growth of HH [21]. Another etiology of HH is
Hemihyperplasia-multiple lipomatosis syndrome (HHMLS), inwhich
the asymmetric growth is secondary to overgrowth of subcutaneous
limpomata [21,22]. PatientswithHHMLShaveno riskofneoplasiaand
often undergo little clinical change throughout life [21,23]. Because
IHHhas an associationwith genetic syndromes, it is important for the
physician managing such a patient to be aware of the possible
neoplastic risks involved [24].Oftenpatientswith IHHpresentearly in
infancy, but their disproportionate bodies are rarely addressed
because care is primarily directed toward neoplastic surveillance of
intra-abdominal organs [22,24], and the disproportion is typically not
severe enough to warrant surgical intervention. Our patient’s pre-
operativework-up, includinggenetics consultation, didnot reveal any
signiﬁcant past medical history indicative of an associated genetic
syndrome; as such, she was appropriately diagnosed with IHH.
Fig. 5. The right lower extremity demonstrates signiﬁcant improvement in symmetry and contour 9 months after surgery (left) anteriorly and (right) posteriorly.
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span, though the hypertrophic side may cause signiﬁcant functional
and aesthetic impairment [8].
Because of the various etiologies of HH, there is also no
consensus on an appropriate surgical approach, and any attempts
at surgical management of hyperplastic body regions have
depended on the etiology of the presenting disorder as well as the
degree of hyperplasia. When initially presented with a patient
with HH, it may be necessary to consult an orthopedic surgeon to
perform an epiphysiodesis to prevent further continued asym-
metrical growth of one lower extremity resulting in pelvic tilt, and
eventual scoliosis [8]. Once the nature of the HH is identiﬁed,
management can be speciﬁcally tailored to the patient. For
example, patients with HHMLS have presented for surgical
improvement of structural form and function wherein liposuction
was the primary method of de-bulking [23]. Because some pa-
tients experience recurrence of lipomas, it has been recommended
to use the most minimally invasive techniques and only when
symptomatic [22].
While our patient’s entire right body was affected, we focused
our efforts on the disproportionately large mass of the right thigh
impairing her gait. Lower extremity imaging revealed that our
patient’s thigh hypertrophy was limited to the adductor
compartment, more speciﬁcally the adductor magnus. After
extensive review of the imaging and associated anatomy, webelieved that surgical resection of the adductor musculature
would signiﬁcantly improve her gait without impairment to the
function of the lower extremity. Intra-operatively, we were able to
preserve the pectineus, adductors brevis and longus, which
allowed for the successful preservation of thigh adduction. How-
ever, it should be noted that had the lipomatous inﬁltration been
more diffuse and involved less forgiving compartments such as
the lower leg surgical management would have carried a greater
risk factor. As such, we suggest that surgical debulking of patients
with IHH can be performed safely if speciﬁc conditions are met.
On return to the clinic, the patient’s rapid gait recovery,
improvement in thigh symmetry, and uneventful wound healing
underscore that surgical management of adolescent patients with
IHH is possible.
3. Conclusion
Isolated hemihyperplasia is a rare condition that is often not
amenable to surgical correction. However, in the subset of pa-
tients where a deﬁned mass is causing undesired aesthetic and/or
orthopedic symptoms, operative treatment is feasible and can
offer signiﬁcant improvement. Preoperative soft tissue imaging,
detailed surgical planning, and careful dissection can allow pres-
ervation of critical neurovascular structures and reduce operative
morbidity.
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